|
2025-03-10 |
2025-03-07 |
S
Sale
|
SHERWIN STEPHEN A
Non-Executive Director
|
8,760
-43.6%
150.02
USD 1,314,142
|
8,760
-43.6%
|
150.02
|
USD 1,314,142
|
|
|
2024-12-09 |
2024-12-09 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
110
-2.0%
157.21
USD 17,293
|
110
-2.0%
|
157.21
|
USD 17,293
|
|
|
2024-09-05 |
2024-09-03 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
431
-7.5%
204.22
USD 88,019
|
431
-7.5%
|
204.22
|
USD 88,019
|
|
|
2024-04-03 |
2024-04-02 |
PS
Planned sale
|
Singhal Priya
Head of Development
Officer
|
93
-1.9%
213.09
USD 19,817
|
93
-1.9%
|
213.09
|
USD 19,817
|
|
|
2024-02-26 |
2024-02-22 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
262
-5.1%
221.23
USD 57,962
|
262
-5.1%
|
221.23
|
USD 57,962
|
|
|
2024-02-21 |
2024-02-16 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
108
-2.1%
221.49
USD 23,921
|
108
-2.1%
|
221.49
|
USD 23,921
|
|
|
2024-02-20 |
2024-02-15 |
B
Purchase
|
Rowinsky Eric K
Non-Executive Director
|
455
+2.3%
222.54
USD 101,256
|
455
+2.3%
|
222.54
|
USD 101,256
|
|
|
2024-02-13 |
2024-02-12 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
419
-8.5%
239.45
USD 100,330
|
419
-8.5%
|
239.45
|
USD 100,330
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
634
-13.4%
245.93
USD 155,920
|
634
-13.4%
|
245.93
|
USD 155,920
|
|
|
2023-12-12 |
2023-12-11 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
110
-3.1%
248.00
USD 27,280
|
110
-3.1%
|
248.00
|
USD 27,280
|
|
|
2023-09-06 |
2023-09-05 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
431
-11.4%
269.43
USD 116,124
|
431
-11.4%
|
269.43
|
USD 116,124
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Singhal Priya
Head of Development
Officer
|
81
-2.7%
282.87
USD 22,912
|
81
-2.7%
|
282.87
|
USD 22,912
|
|
|
2023-05-02 |
2023-04-28 |
PS
Planned sale
|
Gregory Ginger
EVP, Human Resources
Officer
|
2,681
-24.0%
300.00
USD 804,300
|
2,681
-24.0%
|
300.00
|
USD 804,300
|
|
|
2023-04-06 |
2023-04-04 |
PS
Planned sale
|
Singhal Priya
Head of Development
Officer
|
91
-3.1%
277.11
USD 25,217
|
91
-3.1%
|
277.11
|
USD 25,217
|
|
|
2023-03-30 |
2023-03-28 |
PS
Planned sale
|
Singhal Priya
Head of Development
Officer
|
568
-16.7%
270.06
USD 153,394
|
568
-16.7%
|
270.06
|
USD 153,394
|
|
|
2022-12-12 |
2022-11-14 |
PS
Planned sale
|
Gregory Ginger
EVP, Human Resources
Officer
|
5,610
-49.6%
300.11
USD 1,683,617
|
5,610
-49.6%
|
300.11
|
USD 1,683,617
|
|
|
2022-10-28 |
2022-10-27 |
PS
Planned sale
|
ALEXANDER SUSAN H
EVP Chief Legal Off & Corp Sec
Officer
|
5,532
-12.3%
280.70
USD 1,552,832
|
5,532
-12.3%
|
280.70
|
USD 1,552,832
|
|
|
2021-06-09 |
2021-06-07 |
PS
Planned sale
|
Sandrock Alfred
Head of Research & Development
Officer
|
7,672
-43.0%
440.00
USD 3,375,680
|
7,672
-43.0%
|
440.00
|
USD 3,375,680
|
|
|
2021-06-07 |
2021-06-04 |
PS
Planned sale
|
Posner Brian S
Non-Executive Director
|
360
-4.6%
274.17
USD 98,701
|
360
-4.6%
|
274.17
|
USD 98,701
|
|
|
2021-02-10 |
2021-02-09 |
B
Purchase
|
Mantas Jesus B
Non-Executive Director
|
898
+43.9%
267.00
USD 239,766
|
898
+43.9%
|
267.00
|
USD 239,766
|
|
|
2020-12-01 |
2020-11-30 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
3,100
+9.8%
241.31
USD 748,047
|
3,100
+9.8%
|
241.31
|
USD 748,047
|
|
|
2020-11-06 |
2020-11-04 |
PS
Planned sale
|
Sandrock Alfred
EVP, Research & Development
Officer
|
1,500
-10.3%
350.00
USD 525,000
|
1,500
-10.3%
|
350.00
|
USD 525,000
|
|
|
2020-03-12 |
2020-03-11 |
PS
Planned sale
|
SHERWIN STEPHEN A
Non-Executive Director
|
270
-1.7%
295.29
USD 79,728
|
270
-1.7%
|
295.29
|
USD 79,728
|
|
|
2020-03-12 |
2020-03-11 |
PS
Planned sale
|
SHERWIN STEPHEN A
Non-Executive Director
|
2,164
-13.1%
295.22
USD 638,845
|
2,164
-13.1%
|
295.22
|
USD 638,845
|
|
|
2019-12-03 |
2019-12-02 |
PS
Planned sale
|
Posner Brian S
Non-Executive Director
|
1,055
-13.1%
292.35
USD 308,429
|
1,055
-13.1%
|
292.35
|
USD 308,429
|
|
|
2019-05-02 |
2019-05-02 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
38,000
+6.3%
231.24
USD 8,787,120
|
38,000
+6.3%
|
231.24
|
USD 8,787,120
|
|
|
2019-05-02 |
2019-05-01 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
4,351
+26.1%
231.48
USD 1,007,169
|
4,351
+26.1%
|
231.48
|
USD 1,007,169
|
|
|
2019-05-02 |
2019-05-01 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
30,000
+5.2%
229.46
USD 6,883,800
|
30,000
+5.2%
|
229.46
|
USD 6,883,800
|
|
|
2019-05-02 |
2019-04-30 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
50,342
+9.6%
229.25
USD 11,540,904
|
50,342
+9.6%
|
229.25
|
USD 11,540,904
|
|
|
2019-03-19 |
2019-03-18 |
PS
Planned sale
|
PANGIA ROBERT W
|
6,114
-24.8%
328.55
USD 2,008,755
|
6,114
-24.8%
|
328.55
|
USD 2,008,755
|
|
|
2019-02-01 |
2019-02-01 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
7,000
+1.4%
328.45
USD 2,299,163
|
7,000
+1.4%
|
328.45
|
USD 2,299,163
|
|
|
2019-02-01 |
2019-01-31 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
25,800
+5.2%
330.52
USD 8,527,393
|
25,800
+5.2%
|
330.52
|
USD 8,527,393
|
|
|
2019-02-01 |
2019-01-30 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
30,000
+6.5%
324.86
USD 9,745,851
|
30,000
+6.5%
|
324.86
|
USD 9,745,851
|
|
|
2018-09-27 |
2018-09-26 |
PS
Planned sale
|
Ehlers Michael D
EVP, Research and Development
Officer
|
1,000
-18.9%
350.00
USD 350,000
|
1,000
-18.9%
|
350.00
|
USD 350,000
|
|
|
2018-04-27 |
2018-04-25 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
48,000
+11.6%
269.91
USD 12,955,680
|
48,000
+11.6%
|
269.91
|
USD 12,955,680
|
|
|
2018-02-28 |
2018-02-27 |
PS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
259
-3.8%
290.83
USD 75,325
|
259
-3.8%
|
290.83
|
USD 75,325
|
|
|
2018-02-27 |
2018-02-23 |
PS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
908
-12.2%
293.44
USD 266,444
|
908
-12.2%
|
293.44
|
USD 266,444
|
|
|
2018-02-21 |
2018-02-20 |
PS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
743
-10.2%
292.00
USD 216,956
|
743
-10.2%
|
292.00
|
USD 216,956
|
|
|
2018-02-20 |
2018-02-15 |
PS
Planned sale
|
Sandrock Alfred
EVP, Chief Medical Officer
Officer
|
1,294
-15.1%
298.85
USD 386,712
|
1,294
-15.1%
|
298.85
|
USD 386,712
|
|
|
2018-01-10 |
2018-01-09 |
PS
Planned sale
|
PANGIA ROBERT W
Non-Executive Director
|
5,832
-24.8%
329.65
USD 1,922,519
|
5,832
-24.8%
|
329.65
|
USD 1,922,519
|
|
|
2018-01-02 |
2017-12-29 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
780
+19.0%
320.55
USD 250,029
|
780
+19.0%
|
320.55
|
USD 250,029
|
|
|
2017-11-30 |
2017-11-29 |
B
Purchase
|
DENNER ALEXANDER J
|
10,000
+2.5%
319.84
USD 3,198,400
|
10,000
+2.5%
|
319.84
|
USD 3,198,400
|
|
|
2017-11-30 |
2017-11-28 |
B
Purchase
|
DENNER ALEXANDER J
|
20,000
+5.2%
316.12
USD 6,322,400
|
20,000
+5.2%
|
316.12
|
USD 6,322,400
|
|
|
2017-07-26 |
2017-07-25 |
PS
Planned sale
|
ALEXANDER SUSAN H
EVP Chief Legal Corp Svc & Sec
Officer
|
4,974
-18.3%
290.01
USD 1,442,510
|
4,974
-18.3%
|
290.01
|
USD 1,442,510
|
|
|
2017-07-20 |
2017-07-19 |
PS
Planned sale
|
ALEXANDER SUSAN H
EVP Chief Legal Corp Svc & Sec
Officer
|
7,758
-22.2%
285.00
USD 2,211,030
|
7,758
-22.2%
|
285.00
|
USD 2,211,030
|
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
Posner Brian S
|
1,084
-14.6%
256.31
USD 277,840
|
1,084
-14.6%
|
256.31
|
USD 277,840
|
|
|
2017-05-02 |
2017-05-01 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
1,402
+91.9%
271.35
USD 380,433
|
1,402
+91.9%
|
271.35
|
USD 380,433
|
|
|
2017-05-01 |
2017-04-27 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
58,858
+18.1%
278.48
USD 16,390,776
|
58,858
+18.1%
|
278.48
|
USD 16,390,776
|
|
|
2017-05-01 |
2017-04-27 |
B
Purchase
|
DENNER ALEXANDER J
Non-Executive Director
|
15,000
+4.8%
278.58
USD 4,178,700
|
15,000
+4.8%
|
278.58
|
USD 4,178,700
|
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
Clancy Paul J
Executive VP and CFO
|
9,892
-47.8%
290.00
USD 2,868,680
|
9,892
-47.8%
|
290.00
|
USD 2,868,680
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
Sandrock Alfred
EVP CMO Neuro & Neurodegenerat
|
1,981
-21.9%
274.08
USD 542,952
|
1,981
-21.9%
|
274.08
|
USD 542,952
|
|
|
2017-03-14 |
2017-03-13 |
PS
Planned sale
|
Clancy Paul J
Executive VP and CFO
|
9,891
-32.3%
291.55
USD 2,883,721
|
9,891
-32.3%
|
291.55
|
USD 2,883,721
|
|
|
2017-03-03 |
2017-03-01 |
PS
Planned sale
|
Sandrock Alfred
EVP CMO Neuro & Neurodegenerat
|
973
-9.7%
290.07
USD 282,238
|
973
-9.7%
|
290.07
|
USD 282,238
|
|
|
2017-03-01 |
2017-02-27 |
PP
Planned purchase
|
Vounatsos Michel
Chief Executive Officer
Executive Director
|
1,333
+1320.7%
285.39
USD 380,425
|
1,333
+1320.7%
|
285.39
|
USD 380,425
|
|
|
2017-01-10 |
2017-01-09 |
PS
Planned sale
|
PANGIA ROBERT W
Non-Executive Director
|
5,450
-24.7%
295.39
USD 1,609,876
|
5,450
-24.7%
|
295.39
|
USD 1,609,876
|
|
|
2016-12-05 |
2016-12-01 |
PS
Planned sale
|
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
Officer
|
48
-0.6%
296.53
USD 14,233
|
48
-0.6%
|
296.53
|
USD 14,233
|
|
|
2016-10-05 |
2016-10-04 |
PS
Planned sale
|
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
Officer
|
262
-3.3%
311.94
USD 81,728
|
262
-3.3%
|
311.94
|
USD 81,728
|
|
|
2016-10-04 |
2016-10-03 |
PS
Planned sale
|
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
Officer
|
380
-4.6%
313.00
USD 118,940
|
380
-4.6%
|
313.00
|
USD 118,940
|
|
|
2016-09-26 |
2016-09-22 |
PS
Planned sale
|
DORSA CAROLINE
Non-Executive Director
|
27,570
-61.7%
314.00
USD 8,656,980
|
27,570
-61.7%
|
314.00
|
USD 8,656,980
|
|
|
2016-07-22 |
2016-07-21 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
157
-0.3%
280.00
USD 43,960
|
157
-0.3%
|
280.00
|
USD 43,960
|
|
|
2016-06-07 |
2016-06-06 |
PS
Planned sale
|
Koppel Adam
EVP, Strategy and Bus. Dev.
Officer
|
555
-18.8%
290.00
USD 160,950
|
555
-18.8%
|
290.00
|
USD 160,950
|
|
|
2016-06-06 |
2016-06-03 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
842
-1.5%
290.00
USD 244,180
|
842
-1.5%
|
290.00
|
USD 244,180
|
|
|
2016-06-02 |
2016-06-01 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
487
-0.9%
287.97
USD 140,241
|
487
-0.9%
|
287.97
|
USD 140,241
|
|
|
2016-06-02 |
2016-05-31 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
3,368
-5.6%
290.00
USD 976,720
|
3,368
-5.6%
|
290.00
|
USD 976,720
|
|
|
2016-05-27 |
2016-05-25 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
157
-0.3%
280.00
USD 43,960
|
157
-0.3%
|
280.00
|
USD 43,960
|
|
|
2016-05-04 |
2016-05-02 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
487
-0.8%
274.74
USD 133,798
|
487
-0.8%
|
274.74
|
USD 133,798
|
|
|
2016-04-07 |
2016-04-06 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
157
-0.3%
280.00
USD 43,960
|
157
-0.3%
|
280.00
|
USD 43,960
|
|
|
2016-04-07 |
2016-04-06 |
PS
Planned sale
|
Koppel Adam
EVP, Strategy and Bus. Dev.
Officer
|
102
-5.2%
275.00
USD 28,050
|
102
-5.2%
|
275.00
|
USD 28,050
|
|
|
2016-04-05 |
2016-04-01 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
487
-0.8%
258.83
USD 126,050
|
487
-0.8%
|
258.83
|
USD 126,050
|
|
|
2016-03-03 |
2016-03-01 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
487
-0.8%
261.37
USD 127,287
|
487
-0.8%
|
261.37
|
USD 127,287
|
|
|
2016-02-26 |
2016-02-25 |
PS
Planned sale
|
Sandrock Alfred
EVP CMO Neuro & Neurodegenerat
Officer
|
183
-2.2%
261.90
USD 47,928
|
183
-2.2%
|
261.90
|
USD 47,928
|
|
|
2016-02-26 |
2016-02-25 |
PS
Planned sale
|
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
Officer
|
84
-1.0%
261.90
USD 22,000
|
84
-1.0%
|
261.90
|
USD 22,000
|
|
|
2016-02-19 |
2016-02-17 |
PS
Planned sale
|
SCANGOS GEORGE A
Chief Executive Officer
Executive Director
|
487
-0.8%
256.16
USD 124,750
|
487
-0.8%
|
256.16
|
USD 124,750
|
|
|
2016-02-19 |
2016-02-17 |
PS
Planned sale
|
Sandrock Alfred
EVP CMO Neuro & Neurodegenerat
Officer
|
722
-8.3%
256.16
USD 184,948
|
722
-8.3%
|
256.16
|
USD 184,948
|
|
|
2016-02-10 |
2016-02-09 |
PS
Planned sale
|
Sandrock Alfred
EVP CMO Neuro & Neurodegenerat
Officer
|
852
-9.9%
246.54
USD 210,052
|
852
-9.9%
|
246.54
|
USD 210,052
|
|
